Balanced news tone
News Sentiment
7459 sentiment intelligence
MediPal Holdings Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
News tone and price action are not far from neutral.
78/100 classification confidence.
directly relevant articles
high-authority source matches
-0.4% over one week, -0.1% over four weeks, trend inactive, and near fair-value range.
Paltac to be Fully Acquired by MEDIPAL and Delisted from TSE Prime Market
Market Reaction
Balanced read
News tone and price action are not far from neutral.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Paltac to be Fully Acquired by MEDIPAL and Delisted from TSE Prime Market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jul 2026 07:19
- Source
- TipRanks
Medipal Raises Dividend Forecast on Earnings Boost From Paltac Acquisition
- Tone
- Positive 66/100
- Event
- Capital return
- Published
- 14 Jul 2026 07:22
- Source
- TipRanks
Medipal Lifts Net Profit Outlook After Paltac Takeover, Trims Operating Guidance
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 14 Jul 2026 07:22
- Source
- TipRanks
Medipal to Book ¥42.1 Billion in Subsidiary Dividends With No Impact on Consolidated Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 Jul 2026 07:22
- Source
- TipRanks
MEDIPAL Completes Tender Offer to Boost Control Over Paltac
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 08 Jul 2026 06:57
- Source
- TipRanks
Medipal Completes Tender Offer to Boost Stake in Distributor Paltac
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 08 Jul 2026 06:57
- Source
- TipRanks
Medipal Holdings Corp highlights its role in Japan's pharmaceutical distribution. Investors watch lo
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jul 2026 17:32
- Source
- Ad Hoc News
MediPal Holdings Corporation (TSE:7459) Annual Results: Here's What Analysts Are Forecasting For This Year
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 18 May 2026 07:00
- Source
- simplywall.st
Medipal seeks to diversify amid falling drug margins
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 Jul 2025 07:00
- Source
- The Japan Times
MEDIPAL HOLDINGS CORPORATION and JCR Pharmaceuticals Announce Initiation of First Dosing in Phase I/II Clinical Trial of JR-446 for Mucopolysaccharidosis Type IIIB in Japan
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 05 Dec 2024 08:00
- Source
- Business Wire